CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate

Immune to Cancer: The CRI Blog

  • CRI Meets with the Vice President’s Staff on Moonshot

    CRI and Vice President Biden’s Moonshot Initiative collaborate for the advancement of cancer immunotherapy research.

    February 26, 2016| Jill O'Donnell-Tormey, PhD
  • Laurie H. Glimcher, MD, to Head Dana-Farber Cancer Institute

    CRI Scientific Advisory Council member Laurie H. Glimcher, MD, will become the next president and CEO of…

    February 23, 2016| Alexandra Mulvey
  • A Cruise to Cure Cancer

    Because Janet, a travel agent, lost family and friends to cancer, she wanted to create a cruise…

    February 17, 2016| CRI Staff
  • Genetically Engineered CAR T Cells Prove Highly Effective Against Blood Cancers

    The era of powerful, personalized medicine draws near.

    February 17, 2016| Arthur N. Brodsky, PhD
  • FDA Regulatory Definitions

    You heard that a drug in clinical trials was Fast Tracked. Or you heard that a treatment…

    February 12, 2016| Alexandra Mulvey
  • ASCO Names Cancer Immunotherapy “Advance of the Year”

    ASCO President: “No recent cancer advance has been more transformative than immunotherapy.”

    February 5, 2016| Alexandra Mulvey
  • #WeCanICan: The Cure is International

    World Cancer Day is both a celebration of the progress we’ve made so far, and a call…

    February 4, 2016| Alexandra Mulvey
  • Cancer Immunotherapy Reverses Alzheimer’s in Mice

    A checkpoint inhibitor may offer hope for Alzheimer’s patients.

    February 3, 2016| Arthur N. Brodsky, PhD
  • FDA Approval Expands Immunotherapy Options for Advanced Melanoma

    Immunotherapy combinations continue to shine against melanoma.

    January 27, 2016| Arthur N. Brodsky, PhD
Previous Page
1 … 73 74 75 76 77 … 92
Next Page
Father and son

Join CRI in Shaping the Future of Immunotherapy

Support the pioneering work of CRI in advancing immunotherapy.

See ways to give

Cancer Research Institute
29 Broadway, Floor 4

New York, NY  10006-3111

Facebook Icon
X icon
YouTube icon
LinkedIn icon
Instagram icon
Threads icon
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Type
    • Cancer Type
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Donate
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact

Uniting for a World Immune to Cancer

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
  • Site Map

*Immunotherapy results may vary from patient to patient.

©2025, Cancer Research Institute